• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines.自身免疫性炎性风湿性疾病的安全性与疾病复发：一项关于灭活新冠疫苗的大型真实世界调查
Ann Rheum Dis. 2022 Mar;81(3):443-445. doi: 10.1136/annrheumdis-2021-221736. Epub 2021 Nov 25.
2
Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City.纽约市风湿病门诊患者中，SARS-CoV-2疫苗接种后出现系统性风湿性疾病发作。
Ann Rheum Dis. 2021 Oct;80(10):1352-1354. doi: 10.1136/annrheumdis-2021-220732. Epub 2021 Jun 22.
3
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination: A Narrative Review.COVID-19 疫苗接种后全身性自身免疫性风湿病的 flares：一项叙述性综述。
Rheum Dis Clin North Am. 2025 Feb;51(1):75-92. doi: 10.1016/j.rdc.2024.08.005. Epub 2024 Oct 15.
4
The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review.接种 SARS-CoV-2 疫苗后风湿性疾病的 flares：综述。
Front Immunol. 2022 Jul 4;13:919979. doi: 10.3389/fimmu.2022.919979. eCollection 2022.
5
Self-Reported Delayed Adverse Events and Flare Following COVID-19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD-2 Study.马来西亚自身免疫性风湿病（AIRD）患者中新冠病毒疫苗接种后自我报告的延迟不良事件和病情复发：COVAD-2研究结果
Int J Rheum Dis. 2025 Jan;28(1):e70043. doi: 10.1111/1756-185X.70043.
6
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.BNT162b2 mRNA COVID-19 疫苗在成年自身免疫性炎症性风湿病患者和普通人群中的免疫原性和安全性：一项多中心研究。
Ann Rheum Dis. 2021 Oct;80(10):1330-1338. doi: 10.1136/annrheumdis-2021-220647. Epub 2021 Jun 14.
7
Efficacy and safety of inactivated SARS-CoV-2 vaccination in COVID-19-associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real-world retrospective observational study.在风湿免疫疾病患者中，COVID-19 相关肺炎患者中使用灭活 SARS-CoV-2 疫苗的有效性和安全性：一项真实世界回顾性观察研究。
Int J Rheum Dis. 2024 May;27(5):e15166. doi: 10.1111/1756-185X.15166.
8
COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.COVID-19 疫苗接种在自身免疫性炎症性风湿病患者中的应用：韩国风湿病学会的临床指南。
J Korean Med Sci. 2021 Mar 29;36(12):e95. doi: 10.3346/jkms.2021.36.e95.
9
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.与炎症性风湿和肌肉骨骼疾病患者接种 SARS-CoV-2 疫苗后疾病发作相关的因素：来自医生报告的 EULAR 冠状病毒疫苗（COVAX）登记处的结果。
Ann Rheum Dis. 2024 Oct 21;83(11):1584-1595. doi: 10.1136/ard-2024-225869.
10
SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis.SARS-CoV-2 疫苗与 COVID-19 危机中的自身免疫性疾病。
Rheumatol Int. 2021 Mar;41(3):509-518. doi: 10.1007/s00296-021-04792-9. Epub 2021 Jan 30.

引用本文的文献

1
Flares and Predicting Factors of Flares in Patients with Systemic Lupus Erythematosus Associated with Different Doses and Types of COVID-19 Vaccines.系统性红斑狼疮患者接种不同剂量和类型新冠疫苗后的病情复发及复发预测因素
Vaccines (Basel). 2024 Dec 12;12(12):1399. doi: 10.3390/vaccines12121399.
2
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination: A Narrative Review.COVID-19 疫苗接种后全身性自身免疫性风湿病的 flares：一项叙述性综述。
Rheum Dis Clin North Am. 2025 Feb;51(1):75-92. doi: 10.1016/j.rdc.2024.08.005. Epub 2024 Oct 15.
3
Current practice, trends and attitudes of rheumatologists towards glucocorticoids use for rheumatoid arthritis (GURANTEE): a national cross-sectional survey across China.当前中国风湿科医生治疗类风湿关节炎时使用糖皮质激素的现状、趋势和态度（GURANTEE）：一项全国性的横断面调查。
Rheumatol Int. 2024 Nov;44(11):2473-2482. doi: 10.1007/s00296-024-05713-2. Epub 2024 Sep 12.
4
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.与炎症性风湿和肌肉骨骼疾病患者接种 SARS-CoV-2 疫苗后疾病发作相关的因素：来自医生报告的 EULAR 冠状病毒疫苗（COVAX）登记处的结果。
Ann Rheum Dis. 2024 Oct 21;83(11):1584-1595. doi: 10.1136/ard-2024-225869.
5
Safety of COVID-19 Vaccine in Patients with Rheumatic and Musculoskeletal Diseases.新冠病毒疫苗在风湿性和肌肉骨骼疾病患者中的安全性
Mediterr J Rheumatol. 2024 Feb 8;35(1):123-133. doi: 10.31138/mjr.140223.sof. eCollection 2024 Mar.
6
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.类风湿关节炎患者突破性 SARS-CoV-2 感染和疾病加重：来自 COVAD 电子调查研究的结果。
Rheumatol Int. 2024 May;44(5):805-817. doi: 10.1007/s00296-024-05542-3. Epub 2024 Mar 12.
7
Latent Class Analysis Identifies Distinct Phenotypes of Systemic Lupus Erythematosus Predictive of Flares after mRNA COVID-19 Vaccination: Results from the Coronavirus National Vaccine Registry for ImmuNe Diseases SINGapore (CONVIN-SING).潜在类别分析确定系统性红斑狼疮的不同表型，这些表型可预测mRNA新冠疫苗接种后的病情发作：来自新加坡免疫疾病冠状病毒国家疫苗登记处（CONVIN-SING）的结果。
Vaccines (Basel). 2023 Dec 27;12(1):29. doi: 10.3390/vaccines12010029.
8
Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis.接种 SARS-CoV-2 疫苗后免疫介导性疾病患者出现 flares 或复发的风险：一项系统评价和荟萃分析。
Eur J Med Res. 2024 Jan 17;29(1):55. doi: 10.1186/s40001-024-01639-4.
9
"Online survey of COVID-19 immunization and infection in patients with systemic juvenile idiopathic arthritis and adult-onset still's disease.".“COVID-19 疫苗接种和感染的在线调查：系统性幼年特发性关节炎和成人Still 病患者。”
Pediatr Rheumatol Online J. 2023 Nov 21;21(1):139. doi: 10.1186/s12969-023-00911-x.
10
Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study.类风湿关节炎、银屑病关节炎和强直性脊柱炎患者在接种 COVID-19 mRNA 疫苗后出现发作的流行情况和相关因素：一项全国性队列研究。
Adv Rheumatol. 2023 Aug 1;63(1):38. doi: 10.1186/s42358-023-00316-0.

本文引用的文献

1
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.成人系统性风湿病患者 COVID-19 疫苗接种的早期经验：来自 COVID-19 全球风湿病联盟疫苗调查的结果。
RMD Open. 2021 Sep;7(3). doi: 10.1136/rmdopen-2021-001814.
2
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.美国风湿病学会关于风湿和肌肉骨骼疾病患者 COVID-19 疫苗接种的指南：第 3 版。
Arthritis Rheumatol. 2021 Oct;73(10):e60-e75. doi: 10.1002/art.41928. Epub 2021 Aug 4.
3
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.CoronaVac 灭活疫苗在自身免疫性风湿病患者中的免疫原性和安全性：一项 4 期临床试验。
Nat Med. 2021 Oct;27(10):1744-1751. doi: 10.1038/s41591-021-01469-5. Epub 2021 Jul 30.
4
Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study.系统性红斑狼疮患者对新型冠状病毒肺炎疫苗的耐受性：国际VACOLUP研究
Lancet Rheumatol. 2021 Sep;3(9):e613-e615. doi: 10.1016/S2665-9913(21)00221-6. Epub 2021 Jul 21.
5
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.2 种灭活 SARS-CoV-2 疫苗对成人有症状 COVID-19 感染的效果：一项随机临床试验。
JAMA. 2021 Jul 6;326(1):35-45. doi: 10.1001/jama.2021.8565.

Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines.

作者信息

Fan Yong, Geng Yan, Wang Yu, Deng Xuerong, Li Guangtao, Zhao Juan, Ji Lanlan, Zhang Xiaohui, Song Zhibo, Zhang Haoze, Sun Xiaoying, Gao Dai, Xie Wenhui, Huang Hong, Hao YanJie, Zhang Zhuoli

机构信息

Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.

Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China

出版信息

Ann Rheum Dis. 2022 Mar;81(3):443-445. doi: 10.1136/annrheumdis-2021-221736. Epub 2021 Nov 25.

DOI:10.1136/annrheumdis-2021-221736
PMID:34824048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8862022/
Abstract
摘要